Test Price
2,500 AED✅ Home Collection Available
Limb-Girdle Muscular Dystrophy (LGMD) NGS Panel in UAE – 2500 AED
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
🚚 Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
📞 Clinical Guidance: Post-Test Telephonic Clinical Guidance with a DHA-licensed Consultant Medical Genetics.
💳 Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LGMD NGS Panel is a comprehensive genetic test that sequences all known genes associated with limb-girdle muscular dystrophy, enabling precise diagnosis and personalized management. This advanced molecular assay utilizes targeted next-generation sequencing with Sanger confirmation to deliver highly reliable results for patients with suspected LGMD.
| Feature | Our LGMD NGS Panel | Closest Alternative |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity with full gene coverage & copy number analysis | Single-gene sequencing or multi-gene panel with limited CNV detection |
| Methodology | Targeted NGS + Sanger Confirmation per ISO 9001:2015 | Sanger sequencing only or exome sequencing without deep coverage |
| Turnaround Time | 14–21 working days | 4–8 weeks |
| Post-Test Support | Telephonic Clinical Guidance & genetic counseling referral | Limited or no support |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that this comprehensive NGS panel provides critical diagnostic clarity for limb-girdle muscular dystrophy. However, results must always be interpreted within the full clinical context, including neurological examination findings and detailed family history. A negative result does not entirely exclude a genetic etiology; therefore, continued specialist follow-up is essential. Please discuss any concerns directly with your referring physician before making clinical decisions.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medication Advisory
⚠️ Do Not Discontinue Prescribed Therapy
Do not stop, alter, or adjust any prescribed medication or therapy without first consulting your treating physician. Genetic testing results should complement, not replace, clinical judgment and ongoing medical management.
Exclusion Criteria & Emergency Red Flags
Clinical Contraindications
- Patients with acute muscle breakdown (rhabdomyolysis) or unstable cardiac condition should first be stabilized before testing.
- If you experience sudden difficulty breathing, swallowing, or severe chest pain, seek emergency care immediately.
- This test is not recommended for prenatal diagnosis without prior genetic counseling; consult your obstetrician.
Patient FAQ & Clinical Guidance
1. What genes are included in the LGMD NGS Panel?
The panel covers all 30+ genes linked to limb-girdle muscular dystrophy including CAPN3, DYSF, SGCA, SGCB, FKRP, and ANO5, with full exon sequencing and copy number variant analysis.
2. How accurate is this panel for diagnosing LGMD?
The diagnostic sensitivity is 99.9% for known pathogenic variants. Negative results may occur in cases involving novel or deep intronic mutations not captured by current sequencing technology; therefore, ongoing neurological follow-up remains essential.
3. How is the sample collected and what preparation is required?
A simple peripheral whole blood sample is collected by a certified phlebotomist at your home through our VIP Mobile Phlebotomy service (available daily 8 AM to 11 PM). No fasting is required. Please list all current medications and share relevant family history to ensure accurate interpretation.
UAE Regulatory & Data Privacy Adherence
🛡️ Compliance Framework: This test and its associated data handling procedures fully comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory processing is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Limb-Girdle Muscular Dystrophy (LGMD) NGS Panel |
| Price (AED) | 2500 AED |
| Turnaround Time | 14–21 working days |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Targeted NGS + Sanger Confirmation |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 81262-6 |
| DHA Facility License & Lab Address | License No: 1143 | DNA Labs UAE – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians